Fundraising Fox

HeMemics Biotechnologies

Rockville, US · Delaware corporation

Biotech

Founders & leadership

LS
Larry SimpsonNamed on SEC filing
JP
James P. HogartyNamed on SEC filing
DH
David H. HoNamed on SEC filing
BB
Brandon B. HoNamed on SEC filing
BA
Bruce A. CampbellNamed on SEC filing
RS
Roger S. BrookNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$877.5K disclosed across 2 rounds · 2018–2020

▶$100KraisedDec 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hoa NguyenDirector
  • Mary SchmidtDirector
  • Hao NguyenDirector
  • David HoExecutive Officer, Director
  • John WardenExecutive Officer, Director
  • Dann ThomasDirector
  • Maria FattoreExecutive Officer
Offering amount
$1.5M
Amount sold
$100K
Minimum investment
$100K
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$777.5KraisedMay 2018 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry SimpsonDirector
  • James P. HogartyExecutive Officer, Director
  • David H. HoExecutive Officer, Director
  • Brandon B. HoExecutive Officer
  • Bruce A. CampbellExecutive Officer, Director
  • Roger S. BrookExecutive Officer, Director
Offering amount
$2.3M
Amount sold
$777.5K
Minimum investment
$1K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has HeMemics Biotechnologies raised?
HeMemics Biotechnologies has disclosed $877.5K raised across 2 rounds.
Where is HeMemics Biotechnologies headquartered?
HeMemics Biotechnologies is headquartered in Rockville, US.